Journal Article

General Applicability of Existing College of American Pathologists Accreditation Requirements to Clinical Implementation of Machine Learning–Based Methods in Molecular Oncology Testing

Furtado, Larissa V., Huang, Richard S. P., Moncur, Joel T., Zehir, Ahmet, Suarez, Carlos J., Sadri, Navid, Ikemura, Kenji, Vasalos, Patricia, Stellato, Katherine, Benkli, Cagla Y.

2025

Overview

The College of American Pathologists (CAP) accreditation requirements for clinical laboratory testing help ensure laboratories implement and maintain systems and processes that are associated with quality. Machine learning (ML)-based models share some features of conventional laboratory testing methods. Accreditation requirements that specifically address clinical laboratories' use of ML remain in the early stages of development. To identify relevant CAP accreditation requirements that may be applied to the clinical adoption of ML-based molecular oncology assays, and to provide examples of current and emerging ML applications in molecular oncology testing. CAP accreditation checklists related to molecular pathology and general laboratory practices (Molecular Pathology, All Common and Laboratory General) were reviewed. Examples of checklist requirements that are generally applicable to validation, revalidation, quality management, infrastructure, and analytical procedures of ML-based molecular oncology assays were summarized. Instances of ML use in molecular oncology testing were assessed from literature review. Components of the general CAP accreditation framework that exist for traditional molecular oncology assay validation and maintenance are also relevant for implementing ML-based tests in a clinical laboratory. Current and emerging applications of ML in molecular oncology testing include DNA methylation profiling for central nervous system tumor classification, variant calling, microsatellite instability testing, mutational signature analysis, and variant prediction from histopathology images. Currently, much of the ML activity in molecular oncology is within early clinical implementation. Despite specific considerations that apply to the adoption of ML-based methods, existing CAP requirements can serve as general guidelines for the clinical implementation of ML-based assays in molecular oncology testing.

• Publisher: College of American Pathologists
• Subject: Accreditation - standards / Artificial intelligence / Cancer / Diagnosis / Health aspects / Humans / Laboratories, Clinical - standards / Laws, regulations and rules / Machine Learning / Medical Oncology - methods / Medical Oncology - standards / Neoplasms - diagnosis / Neoplasms - genetics / Pathologists / Pathology, Molecular / Pathology, Molecular - methods / Pathology, Molecular - standards / Societies, Medical / Technology application / United States